Document is current
Any future updates will be listed below
-
Authors
Wang, Chengang
Chen, Min
Fang, Yajie
Fu, Yunzhao
Lv, Yingxue
Zhang, Xue
Li, Bowen
Bai, Yihan
Li, Qiyou
Zeng, Yuxiao
He, Xiang-yu
Liu, Hongling
Liu, Yong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82201224)
National Natural Science Foundation of China (82271132)
National Key Research and Development Program of China Stem Cell and Translational Research (2024YFA1108700)
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 27 November 2025
First Online: 7 December 2025
Declarations
:
: The animal study protocol was approved by the Laboratory Animal Welfare and Ethics Committee Of the Third Military Medical University under the project titled “MSC-SEV promotes RPC migration by inhibiting the retinal glial barrier in combined transplantation for the treatment of retinal degeneration and its mechanism” on March 17, 2022 (Approval No. AMUWEC20224712). The hESC line was obtained from the State Key Laboratory of Stem Cells and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences. The study was approved by the Animal and Medical Ethics Committee of the Institute of Zoology, Chinese Academy of Sciences (Ethical No. IOZ15033). Written consent was obtained from the couples or the donor’s parents. Additionally, any potential conflicts of interest related to the research, authorship, and/or publication of this article have been disclosed.
: Not applicable.
: The authors declare no competing interests.
